241 related articles for article (PubMed ID: 17389595)
1. Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance.
Nagle CA; An J; Shiota M; Torres TP; Cline GW; Liu ZX; Wang S; Catlin RL; Shulman GI; Newgard CB; Coleman RA
J Biol Chem; 2007 May; 282(20):14807-15. PubMed ID: 17389595
[TBL] [Abstract][Full Text] [Related]
2. Thioesterase superfamily member 2 promotes hepatic insulin resistance in the setting of glycerol-3-phosphate acyltransferase 1-induced steatosis.
Tillander V; Miniami A; Alves-Bezerra M; Coleman RA; Cohen DE
J Biol Chem; 2019 Feb; 294(6):2009-2020. PubMed ID: 30523156
[TBL] [Abstract][Full Text] [Related]
3. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity.
Wendel AA; Li LO; Li Y; Cline GW; Shulman GI; Coleman RA
Diabetes; 2010 Jun; 59(6):1321-9. PubMed ID: 20200319
[TBL] [Abstract][Full Text] [Related]
4. The role of mitochondrial glycerol-3-phosphate acyltransferase-1 in regulating lipid and glucose homeostasis in high-fat diet fed mice.
Yazdi M; Ahnmark A; William-Olsson L; Snaith M; Turner N; Osla F; Wedin M; Asztély AK; Elmgren A; Bohlooly-Y M; Schreyer S; Lindén D
Biochem Biophys Res Commun; 2008 May; 369(4):1065-70. PubMed ID: 18339309
[TBL] [Abstract][Full Text] [Related]
5. Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation.
Wendel AA; Cooper DE; Ilkayeva OR; Muoio DM; Coleman RA
J Biol Chem; 2013 Sep; 288(38):27299-27306. PubMed ID: 23908354
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice.
Neschen S; Morino K; Hammond LE; Zhang D; Liu ZX; Romanelli AJ; Cline GW; Pongratz RL; Zhang XM; Choi CS; Coleman RA; Shulman GI
Cell Metab; 2005 Jul; 2(1):55-65. PubMed ID: 16054099
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Triglyceride Metabolism. II. Function of mitochondrial GPAT1 in the regulation of triacylglycerol biosynthesis and insulin action.
Gonzalez-Baró MR; Lewin TM; Coleman RA
Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1195-9. PubMed ID: 17158253
[TBL] [Abstract][Full Text] [Related]
8. Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation.
Lindén D; William-Olsson L; Ahnmark A; Ekroos K; Hallberg C; Sjögren HP; Becker B; Svensson L; Clapham JC; Oscarsson J; Schreyer S
FASEB J; 2006 Mar; 20(3):434-43. PubMed ID: 16507761
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target.
Muoio DM; Seefeld K; Witters LA; Coleman RA
Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):783-91. PubMed ID: 10051453
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance.
Zhang D; Liu ZX; Choi CS; Tian L; Kibbey R; Dong J; Cline GW; Wood PA; Shulman GI
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17075-80. PubMed ID: 17940018
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs.
Hammond LE; Neschen S; Romanelli AJ; Cline GW; Ilkayeva OR; Shulman GI; Muoio DM; Coleman RA
J Biol Chem; 2005 Jul; 280(27):25629-36. PubMed ID: 15878874
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific G
Sugaya Y; Satoh H
J Diabetes; 2017 Aug; 9(8):754-763. PubMed ID: 27624922
[TBL] [Abstract][Full Text] [Related]
13. Mice deficient in mitochondrial glycerol-3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol accumulation during lipogenic diet and altered phospholipid fatty acid composition.
Lewin TM; de Jong H; Schwerbrock NJ; Hammond LE; Watkins SM; Combs TP; Coleman RA
Biochim Biophys Acta; 2008; 1781(6-7):352-8. PubMed ID: 18522808
[TBL] [Abstract][Full Text] [Related]
14. GPAT1 Activity and Abundant Palmitic Acid Impair Insulin Suppression of Hepatic Glucose Production in Primary Mouse Hepatocytes.
Zhang C; Steadman M; Santos HP; Shaikh SR; Xavier RM
J Nutr; 2024 Apr; 154(4):1109-1118. PubMed ID: 38354952
[TBL] [Abstract][Full Text] [Related]
15. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.
Oakes ND; Cooney GJ; Camilleri S; Chisholm DJ; Kraegen EW
Diabetes; 1997 Nov; 46(11):1768-74. PubMed ID: 9356024
[TBL] [Abstract][Full Text] [Related]
17. Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation.
Perdomo G; Commerford SR; Richard AM; Adams SH; Corkey BE; O'Doherty RM; Brown NF
J Biol Chem; 2004 Jun; 279(26):27177-86. PubMed ID: 15105415
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats.
Ogihara T; Asano T; Ando K; Chiba Y; Sekine N; Sakoda H; Anai M; Onishi Y; Fujishiro M; Ono H; Shojima N; Inukai K; Fukushima Y; Kikuchi M; Fujita T
Diabetes; 2001 Mar; 50(3):573-83. PubMed ID: 11246877
[TBL] [Abstract][Full Text] [Related]
19. Human 1-acylglycerol-3-phosphate O-acyltransferase isoforms 1 and 2: biochemical characterization and inability to rescue hepatic steatosis in Agpat2(-/-) gene lipodystrophic mice.
Agarwal AK; Sukumaran S; Cortés VA; Tunison K; Mizrachi D; Sankella S; Gerard RD; Horton JD; Garg A
J Biol Chem; 2011 Oct; 286(43):37676-91. PubMed ID: 21873652
[TBL] [Abstract][Full Text] [Related]
20. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
